News | April 14, 2026
Sun Pharma unveils new brand film highlighting shared ‘No. 1’ spirit with Royal Challengers Bengaluru
The campaign builds on the three-year partnership unveiled earlier this season
The campaign builds on the three-year partnership unveiled earlier this season
The license is valid for five years, effective from April 9, 2026
At the centre of this shift is Eli Lilly and Company, whose latest investments in China and Japan are helping redefine the next phase of GLP-1 supply strategy
These surgeries involve no bone cuts, minimal surgical trauma, smaller incisions and significantly reduced blood loss
The partnership aims to fuse antibody-drug conjugation (ADC) technology with targeted protein degradation
The company says the platform offers improved manufacturability and functional advantages
The Stealth AXiS surgical navigation system was recently cleared by the US Food and Drug Administration (FDA) for cranial procedures in the United States
The approval now covers procedures using 10-14F inner diameter and up to 17F outer diameter procedural sheaths
Hyderabad-based peptide specialist strengthens complex generics credentials as Apotex prepares for U.S. commercialization of semaglutide injection
The event showcased latest breakthroughs in minimally invasive surgery, organ-preservation strategies, and targeted therapies
Subscribe To Our Newsletter & Stay Updated
